← FDA Drug Approvals (Drugs@FDA)

SUMATRIPTAN SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2013-09-16

Drug application

FDA Application #
ANDA200183
Application type
Abbreviated New Drug Application (Generic)
Brand name
SUMATRIPTAN SUCCINATE
Generic name
SUMATRIPTAN
Active ingredients
SUMATRIPTAN SUCCINATE
Dosage form
INJECTABLE
Route
SUBCUTANEOUS
Marketing status
Prescription
Sponsor
HIKMA
Manufacturer
Hikma Pharmaceuticals USA Inc.
First approval
2013-09-16

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown